Biodesix
BDSX
42 hedge funds and large institutions have $34.9M invested in Biodesix in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 11 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.33% less ownership
Funds ownership: 19.06% → 15.73% (-3.3%)
11% less funds holding
Funds holding: 47 → 42 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
70% less capital inflows, than outflows
Capital inflows: $5.47M | Capital outflows: $18.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$2.82M |
| 2 |
Morgan Stanley
New York
|
+$616K |
| 3 |
Two Sigma Investments
New York
|
+$370K |
| 4 |
State Street
Boston,
Massachusetts
|
+$347K |
| 5 |
JP Morgan Chase
New York
|
+$335K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$5.78M |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$5.04M |
| 3 |
RTW Investments
New York
|
-$1.65M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.32M |
| 5 |
Essex Investment Management
Boston,
Massachusetts
|
-$1.31M |
BDSX Hedge Fund Activity: Q3 2021 in Review
42 of the 5,732 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q3 2021, worth a combined $34.9M — down 48% from $67.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of BDSX and 6 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 18 added.
The largest buyer was Parian Global Management, adding an estimated $2.82M. The largest seller was Kornitzer Capital Management, exiting entirely with an estimated $5.78M sold.
- 42 institutional investors held Biodesix (BDSX) as of Q3 2021, down from 47 in Q2 2021.
- Funds reported $34.9M of Biodesix stock for Q3 2021, down 48% quarter-over-quarter.
- 6 funds opened new Biodesix positions in Q3 2021 and 11 closed out, a net change of -5 holders.
- The largest Biodesix buyer in Q3 2021 was Parian Global Management, an estimated $2.82M added.
- The largest Biodesix seller in Q3 2021 was Kornitzer Capital Management, an estimated $5.78M sold.
Based on aggregated 13F filings for Q3 2021.